Literature DB >> 25057434

Establishing the Medication Safety Research Network of Indiana (Rx-SafeNet): Perspectives of Community Pharmacy Employees.

Lindsey V Seel1, Kyle E Hultgren2, Margie E Snyder2.   

Abstract

The objective of this cross-sectional survey was to determine community pharmacy employee research project priorities and assess interest levels, barriers, and facilitators to joining a new community pharmacy practice-based research network (PBRN) and use this information in subsequent PBRN development. One hundred forty pharmacists and 40 support staff responded. The majority (72%) of respondents were somewhat interested or needed more information to determine their level of interest in joining a PBRN; 15% were very interested. While all research topics were regarded as important, dispensing errors were rated as the most important. Time constraints were considered the greatest barrier to participation. Greater knowledge of medication safety, enrichment of patient care, and improved patient and provider relationships were considered important reasons for joining a PBRN. Responses indicated favorable interest levels and project support from potential network members, though education and awareness campaigns are needed to enhance community pharmacy employee understanding of and involvement in research and PBRNs, specifically the Medication Safety Research Network of Indiana (Rx-SafeNet), a new network administered by the Purdue University College of Pharmacy. While the generalizability of survey results is limited, they were useful in determining policies and procedures of the new network. Surveying all employees involved in the future PBRN during the network development process is a unique approach to developing these types of networks in the U.S. Understanding support staff perspectives is important considering the critical role they play in project implementation and operations. Emerging PBRNs from any discipline may benefit from considering adding this step to their development.

Entities:  

Keywords:  community pharmacy; medication safety; pharmacy practice; practice-based research networks; research

Year:  2012        PMID: 25057434      PMCID: PMC4104412          DOI: 10.24926/iip.v3i2.262

Source DB:  PubMed          Journal:  Innov Pharm        ISSN: 2155-0417


  8 in total

1.  Independent community pharmacist interest in participating in community pharmacy research networks.

Authors:  Molly B Carr; Holly Divine; Cathy Hanna; Patricia R Freeman; Karen Blumenschein
Journal:  J Am Pharm Assoc (2003)       Date:  2011 Nov-Dec

Review 2.  Primary care practice-based research networks: working at the interface between research and quality improvement.

Authors:  James W Mold; Kevin A Peterson
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

3.  Pharmacy practice-based research networks: why, what, who, and how.

Authors:  Earlene E Lipowski
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Mar-Apr

Review 4.  Strategies for planning and launching PBRN research studies: a project of the Academy of Family Physicians National Research Network (AAFP NRN).

Authors:  Deborah G Graham; Mindy S Spano; Tom V Stewart; Elizabeth W Staton; Angela Meers; Wilson D Pace
Journal:  J Am Board Fam Med       Date:  2007 Mar-Apr       Impact factor: 2.657

5.  Physician perspectives on incentives to participate in practice-based research: a greater rochester practice-based research network (GR-PBRN) study.

Authors:  Karen Gibson; Peter Szilagyi; Carlos M Swanger; Thomas Campbell; Thomas McInerny; Joseph Duckett; Joseph J Guido; Kevin Fiscella
Journal:  J Am Board Fam Med       Date:  2010 Jul-Aug       Impact factor: 2.657

6.  Conducting medication safety research projects in a primary care physician practice-based research network.

Authors:  Grace M Kuo; Jeffrey R Steinbauer; Stephen J Spann
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Mar-Apr

7.  Experience Developing a Community Pharmacy Practice-based Research Network.

Authors:  Margie E Snyder; Caitlin K Frail; Lindsey V Seel; Kyle E Hultgren
Journal:  Innov Pharm       Date:  2012

8.  Barriers, enablers, and incentives for research participation: a report from the Ambulatory Care Research Network (ACRN).

Authors:  Suzanne Bakken; Rafael A Lantigua; Linda V Busacca; J Thomas Bigger
Journal:  J Am Board Fam Med       Date:  2009 Jul-Aug       Impact factor: 2.657

  8 in total
  6 in total

1.  Community pharmacist participation in a practice-based research network: a report from the Medication Safety Research Network of Indiana (Rx-SafeNet).

Authors:  Puja Patel; Heather Hemmeger; Mary Ann Kozak; Stephanie A Gernant; Margie E Snyder
Journal:  J Am Pharm Assoc (2003)       Date:  2015 Nov-Dec

2.  Community pharmacists' and residents' decision making and unmet information needs when completing comprehensive medication reviews.

Authors:  Kacie L McPherson; Omolola A Adeoye-Olatunde; Jayna M Osborne; William R Doucette; Stephanie A Gernant; Heather Jaynes; Shobha Phansalkar; Alissa L Russ-Jara; Margie E Snyder
Journal:  J Am Pharm Assoc (2003)       Date:  2020-01-25

3.  Lessons learned in the growth and maturation stages of a community pharmacy practice-based research network: Experiences of the Medication Safety Research Network of Indiana (Rx-SafeNet).

Authors:  Mary Ann Kozak; Stephanie A Gernant; Heather M Hemmeger; Margie E Snyder
Journal:  Innov Pharm       Date:  2015

4.  Experience Developing a Community Pharmacy Practice-based Research Network.

Authors:  Margie E Snyder; Caitlin K Frail; Lindsey V Seel; Kyle E Hultgren
Journal:  Innov Pharm       Date:  2012

5.  Valuable Lessons for Pharmacist PBRNs: Insights and Experiences from Physician PBRN Members.

Authors:  Lourdes G Planas; Shane P Desselle; Kaitlyn Cao
Journal:  Pharmacy (Basel)       Date:  2019-08-27

6.  An evaluation of the spread and scale of PatientToc™ from primary care to community pharmacy practice for the collection of patient-reported outcomes: A study protocol.

Authors:  Margie E Snyder; Betty Chewning; David Kreling; Susan M Perkins; Lyndee M Knox; Omolola A Adeoye-Olatunde; Heather A Jaynes; Jon C Schommer; Matthew M Murawski; Nisaratana Sangasubana; Lisa A Hillman; Geoffrey M Curran
Journal:  Res Social Adm Pharm       Date:  2020-04-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.